6550--Abbott Architect i1000 Reagents
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
262-NETWORK CONTRACT OFFICE 22 (36C262)
Contract Value
Not provided
Codes & Classification
Solicitation Number
36C26227Q0037
NAICS
325413 - In-Vitro Diagnostic Substance Manufacturing
Classification Code
6550
Additional Details
Documents1
The Department of Veterans Affairs (VA), through its VISN 22 Network Contracting Office, has issued a Sources Sought Request for Information (RFI) to identify qualified vendors capable of supplying immunoassay reagents, consumables, and related supplies for the Abbott Architect i1000 analyzer. This RFI, identified under procurement number 36C26227Q0037, is intended solely for market research and planning purposes and does not constitute a solicitation or a commitment to contract.
The primary objective of this procurement is to ensure the Southern Arizona VA Healthcare System in Tucson, Arizona, has reliable access to FDA-approved reagents, controls, calibration materials, disposables, and other consumable parts necessary for patient testing on its existing Abbott Architect i1000 analyzer. The VA seeks to identify sources that can provide either the specified Abbott brand-name products or equivalent items that meet all salient characteristics. These characteristics include FDA approval and full compatibility with the Architect i1000 analyzer without the need for alteration.
The scope of the requirement encompasses a comprehensive list of reagents and consumables, including but not limited to SHBG and Tacrolimus reagents, calibrator kits, control kits, buffer filters, probes, reaction vessels, wash buffers, and various tubing and assembly components. Estimated quantities for each item are provided to guide potential respondents in assessing their capacity to fulfill the VA’s needs.
Interested parties are encouraged to submit information regarding their business size and status (e.g., Service-Disabled Veteran Owned Small Business, Woman Owned Small Business, etc.), their classification under NAICS code 325413 (In-Vitro Diagnostic Substance Manufacturing, size standard 1,250 employees), and whether they are manufacturers or authorized distributors of the required items. Respondents should also clarify if they hold relevant federal supply contracts (such as GSA, NAC, or NASA SEWP), provide general pricing for market research, and demonstrate their ability to meet the salient characteristics, especially for “equal” products.
All responses must be submitted via email to the primary point of contact, Samuel Han ([email protected]), no later than 1:00 p.m. Pacific Time on October 22, 2026. Telephone responses will not be accepted. The information collected will inform the VA’s acquisition strategy and may lead to a formal solicitation at a later date. However, responses to this RFI do not constitute offers and will not result in contract awards.
The place of performance for this requirement is Tucson, Arizona. The procurement is classified under Product Service Code 6550 (In Vitro Diagnostic Substances, Reagents, Test Kits and Sets). The contracting entity is the 262-Network Contract Office 22, a federal office within the Department of Veterans Affairs.
Contractors evaluating this opportunity should note that the VA is seeking sources with the capability to provide high-quality, compatible immunoassay reagents and consumables on an as-needed basis, ensuring uninterrupted clinical testing services for veterans. The VA emphasizes the importance of FDA approval and seamless integration with existing laboratory equipment. This RFI is a critical step in identifying qualified suppliers and shaping the future solicitation to best meet the needs of the Southern Arizona VA Healthcare System.
For further details and to access the official notice, interested parties may refer to the SAM.gov opportunity at: https://sam.gov/opp/46986f53fdc54057997684c3a328a890/view.